Jonathan Fintzi

National Institute of Allergy and Infectious Diseases

MedicineMathematics

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 27 papers. Top paper: “Examining protective effects of SARS-CoV-2 neutralizing antibodies after vaccination or monoclonal antibody administration”.

Examining protective effects of SARS-CoV-2 neutralizing antibodies after vaccination or monoclonal antibody administration

Nature Communications(2023)10.1038/s41467-023-39292-w

N/A

1.9DataRank · unranked

44 citations

Meagan P. O’Brien, Jonathan Fintzi, Michael P. Fay, David C. Montefiori, Allyson Mateja +19 more

Malaria transmission-blocking vaccines Pfs230D1-EPA and Pfs25-EPA in Alhydrogel in healthy Malian adults; a phase 1, randomised, controlled trial

The Lancet Infectious Diseases(2023)10.1016/s1473-3099(23)00276-1

N/A

1.5DataRank · unranked

52 citations

Sara A. Healy, Mahamadoun H. Assadou, Mamady Koné, Bruce Swihart, Jennifer Kwan +34 more

Omicron COVID-19 immune correlates analysis of a third dose of mRNA-1273 in the COVE trial

Nature Communications(2024)10.1038/s41467-024-52348-9

N/A

0.428DataRank · unranked

9 citations

Youyi Fong, Jonathan Fintzi, Eric Chun‐Pu Chu, Holly Janes, Avi Kenny +37 more

Neutralizing antibody immune correlates in COVAIL trial recipients of an mRNA second COVID-19 vaccine boost

Nature Communications(2025)10.1038/s41467-025-55931-w

N/A

0.345DataRank · unranked

9 citations

Youyi Fong, Lauren Dang, Jonathan Fintzi, Shiyu Chen, Jing Wang +43 more

Semiparametric modeling of SARS-CoV-2 transmission using tests, cases, deaths, and seroprevalence data

The Annals of Applied Statistics(2024)10.1214/24-aoas1882

N/A

0.292DataRank · unranked

6 citations

Isaac Goldstein, Jonathan Fintzi, Keith Lumbard, Emily Ricotta, Sarah Warner +11 more

Neutralizing Antibody Immune Correlates for a Recombinant Protein Vaccine in the COVAIL Trial

Clinical Infectious Diseases(2024)10.1093/cid/ciae465

N/A

0.251DataRank · unranked

3 citations

Lauren Dang, Bo Zhang, Jonathan Fintzi, Shiyu Chen, Jing Wang +84 more

Concordance of immunological events between intrarectal and intravenous SHIVAD8-EO infection when assessed by Fiebig-equivalent staging

Journal of Clinical Investigation(2021)10.1172/jci151632

N/A

0DataRank · unranked

7 citations

Giulia Fabozzi, Kylie March, Mangaiarkarasi Asokan, Cassandra Almasri, Jonathan Fintzi +11 more

Immune Correlates of Protection by mRNA-1273 Immunization against SARS-CoV-2 Infection in Nonhuman Primates

bioRxiv (Cold Spring Harbor Laboratory)(2021)10.1101/2021.04.20.440647

N/A

0DataRank · unranked

51 citations

Martha Nason, Britta Flach, Matthew Gagné, Sarah O’ Connell, Timothy S. Johnston +59 more

Discovering disease-causing pathogens in resource-scarce Southeast Asia using a global metagenomic pathogen monitoring system

medRxiv(2021)10.1101/2021.09.25.21262905

N/A

0DataRank · unranked

9 citations

Sreyngim Lay, Sophana Chea, Vida Ahyong, Daniel M. Parker, Shannon Gallagher +23 more

Assessing vaccine durability in randomized trials following placebo crossover

Statistics in Medicine(2021)10.1002/sim.9001

N/A

0DataRank · unranked

0 citations

Dean Follmann, Jonathan Fintzi

Unraveling the Treatment Effect of Baricitinib on Clinical Progression and Resource Utilization in Hospitalized COVID-19 Patients: Secondary Analysis of the Adaptive COVID-19 Treatment Randomized Trial-2

Open Forum Infectious Diseases(2022)10.1093/ofid/ofac219

N/A

0DataRank · unranked

2 citations

Tyler Bonnett, Pablo Tebas, Vincent C. Marconi, Corri B. Levine, Hana M. El Sahly +14 more

Impact of Surge Strain and Pandemic Progression on Prognostication by an Established COVID-19–Specific Severity Score

Critical Care Explorations(2023)10.1097/cce.0000000000001021

N/A

0DataRank · unranked

3 citations

Jing Wang, Jonathan Fintzi, Alex Mancera, Michael B. Keller, Sarah Warner +2 more

Examining protective effects of SARS-CoV-2 neutralizing antibodies after vaccination or monoclonal antibody administration

UNC Libraries(2023)10.17615/gg43-ax44

N/A

0DataRank · unranked

0 citations

David Benkeser, Baden L.R., Holly Janes, David C. Montefiori, Isa F. +19 more

A Deferred-Vaccination Design to Assess Durability of COVID-19 Vaccine Effect After the Placebo Group Is Vaccinated

UNC Libraries(2023)10.17615/wz35-3h79

N/A

0DataRank · unranked

0 citations

Michael P. Fay, Dean Follmann, Deborah Donnell, James G. Kublin, Myron S. Cohen +24 more

Cardiovascular complications in vascular connective tissue disorders after COVID-19 infection and vaccination

PLoS ONE(2024)10.1371/journal.pone.0315499

N/A

0DataRank · unranked

1 citations

Allyson Mateja, Gretchen MacCarrick, Jonathan Fintzi, Erica Brittain, Pamela A. Frischmeyer‐Guerrerio +2 more

Web-based survey investigating cardiovascular complications in hypermobile Ehlers-Danlos syndrome after COVID-19 infection and vaccination

PLoS ONE(2024)10.1371/journal.pone.0298272

N/A

0DataRank · unranked

2 citations

Allyson Mateja, Gretchen MacCarrick, Jonathan Fintzi, Erica Brittain, Pamela A. Frischmeyer‐Guerrerio +2 more

Omicron COVID-19 immune correlates analysis of a third dose of mRNA-1273 in the COVE trial

UNC Libraries(2024)10.17615/18qe-2h49

N/A

0DataRank · unranked

0 citations

Fichtenbaum C.J, Youyi Fong, Isabel Reeder, Gilbert P.B., Spyros A. Kalams +34 more

Assessing treatment efficacy for interval-censored endpoints using multistate semi-Markov models fit to multiple data streams

Biostatistics(2024)10.1093/biostatistics/kxaf038

N/A

0DataRank · unranked

0 citations

Chengcai Liang, Allyson Mateja, Dean Follmann, Meagan P. O’Brien, Chenguang Wang +2 more

The risk of NTM pulmonary infection associated with trace metal exposure from public distribution system water in the United States

Journal of Exposure Science & Environmental Epidemiology(2025)10.1038/s41370-025-00807-w

N/A

0DataRank · unranked

2 citations

Collin Powell, Stephen T. Nelson, Jonathan Fintzi, Joshua P. French, Rachel A. Mercaldo +3 more

Assessing treatment efficacy for interval-censored endpoints using multistate semi-Markov models fit to multiple data streams

arXiv (Cornell University)(2025)10.48550/arxiv.2501.14097

N/A

0DataRank · unranked

0 citations

Chengcai Liang, Allyson Mateja, Dean Follmann, Meagan P. O’Brien, Chenguang Wang +2 more

An immune-based biomarker signature is associated with mortality in COVID-19 patients

JCI Insight(2020)10.1172/jci.insight.144455

N/A

0DataRank · unranked

369 citations

Ottavia M. Delmonte, Emily Ricotta, Jonathan Fintzi, Danielle Fink, Adriana A. de Jesus +40 more

A Test-Negative Design for Immune Correlates Approximates a Traditional Exposure-Proximal Design but Requires Far Fewer Blood Samples

The Journal of Infectious Diseases(2025)10.1093/infdis/jiaf572

N/A

0DataRank · unranked

0 citations

Lauren Dang, Eric Chun‐Pu Chu, Jonathan Fintzi, Holly Janes, Peter B. Gilbert +13 more

Comparison of the transmission efficiency and plague progression dynamics associated with two mechanisms by which fleas transmit Yersinia pestis

PLoS Pathogens(2020)10.1371/journal.ppat.1009092

N/A

0DataRank · unranked

20 citations

Clayton O. Jarrett, Dana Scott, Jonathan Fintzi, B. Joseph Hinnebusch, Christopher F. Bosio

Assessing Durability of Vaccine Effect Following Blinded Crossover in COVID-19 Vaccine Efficacy Trials

medRxiv(2020)10.1101/2020.12.14.20248137

N/A

0DataRank · unranked

25 citations

Jonathan Fintzi, Michael P. Fay, Holly Janes, Lindsey R. Baden, Hana M. El Sahly +25 more

Immune correlates of protection by mRNA-1273 vaccine against SARS-CoV-2 in nonhuman primates

Science(2021)10.1126/science.abj0299

N/A

0DataRank · unranked

330 citations

Martha Nason, Britta Flach, Matthew Gagné, Sarah O’Connell, Timothy S. Johnston +59 more

Contributions of lipopolysaccharide and the type IVB secretion system to Coxiella burnetii vaccine efficacy and reactogenicity

npj Vaccines(2021)10.1038/s41541-021-00296-6

N/A

0DataRank · unranked

34 citations

Paul A. Beare, Diane C. Cockrell, Jonathan Fintzi, Mahelat Tesfamariam, Carl Shaia +2 more

Deconstructing the Treatment Effect of Remdesivir in the Adaptive Coronavirus Disease 2019 (COVID-19) Treatment Trial-1: Implications for Critical Care Resource Utilization

Clinical Infectious Diseases(2021)10.1093/cid/ciab712

N/A

0DataRank · unranked

16 citations

Tyler Bonnett, Daniel A. Sweeney, Nikhil Huprikar, Anuradha Ganesan, Maria G. Frank +5 more